Subscribe to Newsletter

Content by Stephanie Vine:

Manufacture Small Molecules

Think Small

| Stephanie Vine

Researchers create micro-feeder that eases the handling of small quantities of powder.

Manufacture COVID-19

Fancy a Game of Ping-Pong?

| Stephanie Vine

When following COVID-19 research, it’s hard to keep your eye on the ball...

Discovery & Development Drug Discovery

Mass Spec Meets Machine learning

| Stephanie Vine

Can machine learning offer mass spectrometry a boost for drug discovery?

Business & Regulation Business Practice

Business in Brief

| Stephanie Vine

Power testing partnership, NASH breakthrough designation, and new CEO appointments. What’s new for pharma in business?

Discovery & Development Clinical Trials

Pandemic Protection

| Stephanie Vine

Fujifilm Toyama's influenza treatment passes COVID-19 trial.

Manufacture Vaccines

Don’t Exclude the Aged

| Stephanie Vine

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

Business & Regulation Standards & Regulation

Importation Action

| Stephanie Vine

How will new guidance issued by the FDA affect drug importation?

Manufacture Vaccines

Save Our Shots!

| Stephanie Vine

GlaxoSmithKline has launched a vaccine awareness campaign in the USA as immunization rates drop amidst the pandemic.

Manufacture Bioprocessing - Single Use Systems

The Power List 2021: Nominate Now

| Stephanie Vine

Nominations are now open for The Medicine Maker 2021 Power List.

Manufacture Advanced Medicine

The Genomic Revolution

| Stephanie Vine

Can genomic medicine usher in a new era of curative treatments for neurological diseases? Experts from Sangamo give their views.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register